Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi : Impact Factor & More
pISSN: 0253-2727
Share this on:
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi Journal Specifications
Indexed in the following public directories
Scopus 
SJR
| Overview | |
| Publisher | Zhongguo Yixue Kexueyuan |
Planning to publish in Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
Variables associated with severe cytopenia in adult chronic phase chronic myeloid leukemia patients receiving initial tyrosine kinase inhibitors
- 14 Mar 2026
- Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
Treatment practice and outcomes in 125 patients with autoimmune hemolytic anemia: a single-center retrospective analysis
- 14 Mar 2026
- Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
Niemann-Pick disease with two missense mutations in SMPD1 gene: a case report and literature review
- 14 Mar 2026
- Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
A single-center study on the clinical characteristics of 15 cases of large granular lymphocytic leukemia
- 14 Mar 2026
- Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
Caplacizumab combined with therapeutic plasma exchange, glucocorticoids, and rituximab for refractory thrombotic thrombocytopenic purpura: a case report and literature review
- 14 Mar 2026
- Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
Comparison of the efficacy and safety of venetoclax plus azacitidine versus D-CAG regimen in the treatment of elderly patients with relapsed or refractory acute myeloid leukemia
- 14 Mar 2026
- Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
Variables associated with severe cytopenia in adult chronic phase chronic myeloid leukemia patients receiving initial tyrosine kinase inhibitors
- 14 Mar 2026
- Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
Treatment practice and outcomes in 125 patients with autoimmune hemolytic anemia: a single-center retrospective analysis
- 14 Mar 2026
- Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
Niemann-Pick disease with two missense mutations in SMPD1 gene: a case report and literature review
- 14 Mar 2026
- Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
A single-center study on the clinical characteristics of 15 cases of large granular lymphocytic leukemia
- 14 Mar 2026
- Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
Caplacizumab combined with therapeutic plasma exchange, glucocorticoids, and rituximab for refractory thrombotic thrombocytopenic purpura: a case report and literature review
- 14 Mar 2026
- Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
Comparison of the efficacy and safety of venetoclax plus azacitidine versus D-CAG regimen in the treatment of elderly patients with relapsed or refractory acute myeloid leukemia
- 14 Mar 2026
- Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
FAQs on Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
How many articles did Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi publish last year? 
Who is the publisher of Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi?
Check if your manuscript is a good match for
undefined
Upload your manuscript to get recommendations of journals
that have published papers similar to your manuscript
Drag and drop your file here
We accept manuscripts in English. File format: .doc and .docx | Maximum size: 10 MB | Word count: 200-300,000 words | File length: less than 100 pages
Do not have a manuscript right now? Use an abstract or summary
Your document is 100% secure & confidential We use 256-bit encryption for total security and
ISO/IEC 27001:2013 Certified
What all does the report include
01. Degree of Match
02. Common Topics
03. Additional
Recommendations
Recommendations